JP2013524892A5 - - Google Patents

Download PDF

Info

Publication number
JP2013524892A5
JP2013524892A5 JP2013505189A JP2013505189A JP2013524892A5 JP 2013524892 A5 JP2013524892 A5 JP 2013524892A5 JP 2013505189 A JP2013505189 A JP 2013505189A JP 2013505189 A JP2013505189 A JP 2013505189A JP 2013524892 A5 JP2013524892 A5 JP 2013524892A5
Authority
JP
Japan
Prior art keywords
patient
time
treatment session
hemodialysis
dialysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013505189A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013524892A (ja
JP5747072B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/032735 external-priority patent/WO2011130668A1/en
Publication of JP2013524892A publication Critical patent/JP2013524892A/ja
Publication of JP2013524892A5 publication Critical patent/JP2013524892A5/ja
Application granted granted Critical
Publication of JP5747072B2 publication Critical patent/JP5747072B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013505189A 2010-04-16 2011-04-15 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化 Expired - Fee Related JP5747072B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32511310P 2010-04-16 2010-04-16
US61/325,113 2010-04-16
PCT/US2011/032735 WO2011130668A1 (en) 2010-04-16 2011-04-15 Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015096421A Division JP6078582B2 (ja) 2010-04-16 2015-05-11 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化

Publications (3)

Publication Number Publication Date
JP2013524892A JP2013524892A (ja) 2013-06-20
JP2013524892A5 true JP2013524892A5 (enExample) 2014-01-16
JP5747072B2 JP5747072B2 (ja) 2015-07-08

Family

ID=44041518

Family Applications (8)

Application Number Title Priority Date Filing Date
JP2013505190A Expired - Fee Related JP6018567B2 (ja) 2010-04-16 2011-04-15 腎不全血液治療、特に、家庭血液透析のための治療予測および最適化
JP2013505189A Expired - Fee Related JP5747072B2 (ja) 2010-04-16 2011-04-15 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2015096421A Active JP6078582B2 (ja) 2010-04-16 2015-05-11 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2015178146A Expired - Fee Related JP6043850B2 (ja) 2010-04-16 2015-09-10 腎不全血液治療、特に、家庭血液透析のための治療予測および最適化
JP2017005263A Expired - Fee Related JP6543279B2 (ja) 2010-04-16 2017-01-16 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2019111351A Active JP7057321B2 (ja) 2010-04-16 2019-06-14 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2022063908A Active JP7438257B2 (ja) 2010-04-16 2022-04-07 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2024019498A Pending JP2024045513A (ja) 2010-04-16 2024-02-13 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013505190A Expired - Fee Related JP6018567B2 (ja) 2010-04-16 2011-04-15 腎不全血液治療、特に、家庭血液透析のための治療予測および最適化

Family Applications After (6)

Application Number Title Priority Date Filing Date
JP2015096421A Active JP6078582B2 (ja) 2010-04-16 2015-05-11 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2015178146A Expired - Fee Related JP6043850B2 (ja) 2010-04-16 2015-09-10 腎不全血液治療、特に、家庭血液透析のための治療予測および最適化
JP2017005263A Expired - Fee Related JP6543279B2 (ja) 2010-04-16 2017-01-16 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2019111351A Active JP7057321B2 (ja) 2010-04-16 2019-06-14 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2022063908A Active JP7438257B2 (ja) 2010-04-16 2022-04-07 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2024019498A Pending JP2024045513A (ja) 2010-04-16 2024-02-13 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化

Country Status (10)

Country Link
EP (3) EP2558966B1 (enExample)
JP (8) JP6018567B2 (enExample)
AU (2) AU2011239489B2 (enExample)
BR (1) BR112012026361A2 (enExample)
CA (2) CA2796496C (enExample)
CO (3) CO6660434A2 (enExample)
ES (2) ES2501715T3 (enExample)
MX (5) MX389975B (enExample)
NZ (2) NZ602996A (enExample)
WO (2) WO2011130668A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8845570B2 (en) 2010-04-16 2014-09-30 Baxter International Inc. Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
US9132219B2 (en) 2010-04-16 2015-09-15 Baxter International Inc. Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis
ES2717130T3 (es) * 2013-08-16 2019-06-19 Baxter Int Optimización de terapia de potasio sérico para hemoterapia de insuficiencia renal, especialmente hemodiálisis domiciliaria
DE102014005122A1 (de) * 2014-04-08 2015-10-08 Fresenius Medical Care Deutschland Gmbh Verfahren zur Abschätzung der Behandlungsdauer einer Pertionealdialyse-Behandlung
WO2016057982A1 (en) 2014-10-10 2016-04-14 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
WO2018017623A1 (en) 2016-07-18 2018-01-25 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
EP3506962B1 (en) 2016-08-30 2023-11-22 NxStage Medical, Inc. Parameter monitoring in medical treatment systems
JP2019212249A (ja) * 2018-06-10 2019-12-12 大 益満 プログラム及び情報処理システム
CN114245924A (zh) 2019-03-11 2022-03-25 费森尤斯医疗保健控股公司 用于确定酸碱稳态的技术
WO2020237228A1 (en) 2019-05-23 2020-11-26 Nxstage Medical, Inc. Flow synchronization devices, methods and systems
CN115050238B (zh) * 2022-07-08 2024-03-12 卡斯柯信号有限公司 一种基于真实ctc系统的多模式切换仿真实训系统
JP2024113409A (ja) 2023-02-09 2024-08-22 フィジオロガス・テクノロジーズ株式会社 診療支援システム

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US5230702A (en) * 1991-01-16 1993-07-27 Paradigm Biotechnologies Partnership Hemodialysis method
CA2124808A1 (en) * 1992-10-13 1994-04-28 Vernon H. Troutner Fluid sampling module
JP2812460B2 (ja) * 1995-10-04 1998-10-22 日機装株式会社 血液浄化モニタ装置
JP3402360B2 (ja) * 1998-08-21 2003-05-06 株式会社ジェイ・エム・エス 腹膜透析システム
AUPP790898A0 (en) * 1998-12-23 1999-01-28 Life Therapeutics Limited Renal dialysis
DE60204883T3 (de) * 2002-09-05 2013-10-24 Gambro Lundia Ab Steuerung für eine Blutbehandlungsvorrichtung
US20040048837A1 (en) * 2002-09-06 2004-03-11 Lazarus J. Michael Method for treatment of renal disease
JP4379027B2 (ja) * 2003-05-14 2009-12-09 株式会社ジェイ・エム・エス 腹膜透析および血液透析併用プランニング方法ならびに腹膜透析および血液透析併用プランニング装置
JP4653218B2 (ja) * 2005-06-09 2011-03-16 ガンブロ・ルンディア・エービー 医療機器および医療機器をセットアップするための方法
DE102006045437A1 (de) * 2006-09-26 2008-04-03 Fresenius Medical Care Deutschland Gmbh Vorrichtung und Verfahren zur Vorgabe einer Dialysierflüssigkeitsrate oder Blutflussrate für eine extrakorporale Blutbehandlung
US20080253911A1 (en) 2007-02-27 2008-10-16 Deka Products Limited Partnership Pumping Cassette
US20090107335A1 (en) 2007-02-27 2009-04-30 Deka Products Limited Partnership Air trap for a medical infusion device
US8393690B2 (en) 2007-02-27 2013-03-12 Deka Products Limited Partnership Enclosure for a portable hemodialysis system
US9028691B2 (en) 2007-02-27 2015-05-12 Deka Products Limited Partnership Blood circuit assembly for a hemodialysis system
US8562834B2 (en) 2007-02-27 2013-10-22 Deka Products Limited Partnership Modular assembly for a portable hemodialysis system
US8042563B2 (en) 2007-02-27 2011-10-25 Deka Products Limited Partnership Cassette system integrated apparatus
US8409441B2 (en) * 2007-02-27 2013-04-02 Deka Products Limited Partnership Blood treatment systems and methods
WO2009019535A1 (en) * 2007-08-03 2009-02-12 Koninklijke Philips Electronics N.V. A method, apparatus, computer-readable medium and use for pharmacokinetic modeling
US9514283B2 (en) 2008-07-09 2016-12-06 Baxter International Inc. Dialysis system having inventory management including online dextrose mixing
US8062513B2 (en) * 2008-07-09 2011-11-22 Baxter International Inc. Dialysis system and machine having therapy prescription recall
US8168063B2 (en) * 2008-07-09 2012-05-01 Baxter International Inc. Dialysis system having filtering method for determining therapy prescriptions
US8057679B2 (en) 2008-07-09 2011-11-15 Baxter International Inc. Dialysis system having trending and alert generation
US7981281B2 (en) 2008-07-09 2011-07-19 Baxter International, Inc. Dialysis system having regimen generation methodology
EP2163272B1 (en) * 2008-09-15 2014-06-25 B. Braun Avitum AG Device to early predict the Kt/V parameter in kidney substitution treatments
AU2009305602B2 (en) * 2008-10-17 2012-08-16 Fresenius Medical Care Holdings, Inc. Method of determining a phosphorus binder dosage for a dialysis patient

Similar Documents

Publication Publication Date Title
JP2013524892A5 (enExample)
JP2016535644A5 (enExample)
Shiffman et al. Living donor liver transplantation: summary of a conference at The National Institutes of Health
Daugirdas et al. Anthropometrically estimated total body water volumes are larger than modeled urea volume in chronic hemodialysis patients: effects of age, race, and gender
JP7438257B2 (ja) 腎不全血液療法、特に、在宅血液透析のための療法の予測および最適化
JP2013506845A5 (enExample)
Ng et al. Universal GFR determination based on two time points during plasma iohexol disappearance
Bankhead et al. Accuracy of urea removal estimated by kinetic models
WO2011041697A1 (en) Method of calculating a phosphorus-protein ratio
Di Filippo et al. How to determine ionic dialysance for the online assessment of delivered dialysis dose
Duranton et al. The saga of two centuries of urea: nontoxic toxin or vice versa?
Kloppenburg et al. Anthropometry-based equations overestimate the urea distribution volume in hemodialysis patients
Goldau et al. Ionic dialysance measurement is urea distribution volume dependent: a new approach to better results
Stegeman et al. Determination of protein catabolic rate in patients on chronic intermittent hemodialysis: Urea output measurements compared with dietary protein intake and with calculation of urea generation rate
Mogharab et al. Dialysis adequacy in chronic hemodialysis patients in educational center Vali-Asr in Birjand
Chen et al. Estimating creatinine clearance in the nonsteady state: The determination and role of the true average creatinine concentration
Villa et al. Methods for dose quantification in continuous renal replacement therapy: Toward a more precise approach
Smye et al. A mathematical analysis of a two-compartment model of urea kinetics
Hegbrant et al. Residual renal phosphate clearance in patients receiving hemodialysis or hemodiafiltration
CN105444862A (zh) 一种腹膜透析瘦体重检测装置
Daugirdas Changes in total protein concentration due to fluid removal during and shortly after hemodialysis
CN100493630C (zh) 腹膜透析和血液透析并用计划方法以及腹膜透析和血液透析并用计划装置
Ruggero et al. New models of phosphate kinetics in dialysis patients
Diaz et al. Urea Kinetic Modeling for Guiding Hemodialysis Therapy in Adults
Micic et al. Nitrogen Balance: Revisiting Clinical Applications in Contemporary Practice